Clinical trial
Cardiovascular Risk Predictors in Patients With Psoriasis
NCT05200598 is registered in ClinicalTrials.gov with I.M. Sechenov First Moscow State Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cardiovascular Risk Predictors in Patients With Psoriasis
- Lead sponsor
- I.M. Sechenov First Moscow State Medical University
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 1, 2021
- Completion date
- September 1, 2024
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.